Pruritus in chronic liver disease: Mechanisms and treatment

被引:12
作者
Bergasa N.V. [1 ]
机构
[1] Division of Digestive/Liver Diseases, Columbia Univ. Coll. of Phys./Surg., New York, NY 10032
关键词
Naloxone; Ondansetron; Primary Biliary Cirrhosis; Cholestasis; Naltrexone;
D O I
10.1007/s11894-004-0020-7
中图分类号
学科分类号
摘要
Pruritus is a complication of liver disease. It can have a marked negative impact on quality of life; when intractable, it is an indication for liver transplantation. The cause of this type of pruritus is unknown. There is, however, evidence to suggest that the pruritus associated with liver disease is mediated, at least in part, by endogenous opioids. A central mechanism has been proposed. Therapeutic interventions have concentrated on the removal of presumed and unknown pruritogens from the circulation, hepatic enzyme induction, and, over the past decade, opiate antagonists, the first specific treatment for the pruritus of cholestasis. Other pharmacologic interventions that change neurotransmission have recently been reported to decrease the pruritus in patients with liver disease, as has a newly developed system that applies albumin-based dialysis. These interventions are promising, but they must be tested in properly controlled behavioral trials. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:10 / 16
页数:6
相关论文
共 82 条
[31]  
Lebovics E., Seif F., Kim D., Et al., Pruritus in chronic hepatitis C, Dig. Dis. Sci., 42, pp. 1094-1099, (1997)
[32]  
Chia S.C., Bergasa N.V., Kleiner D.E., Et al., Pruritus as a presenting symptom of chronic hepatitis C, Dig. Dis. Sci., 43, pp. 2177-2183, (1998)
[33]  
Doria C., Mandala L., Smith J., Et al., Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus, Liver Transpl., 9, pp. 437-443, (2003)
[34]  
Savin J., Paterson W., Oswald I., Scratching during sleep, Lancet, 2, pp. 296-297, (1973)
[35]  
Savin J., Paterson W., Oswald I., Adam K., Further studies of scratching during sleep, Br. J. Dermatol., 93, pp. 297-302, (1975)
[36]  
Talbot T.L., Schmitt J.M., Bergasa N.V., Et al., Application of piezo film technology for the quantitative assessment of pruritus, Biomed. Instrum. Technol., 25, pp. 400-403, (1991)
[37]  
Molenaar H.A., Oosting J., Jones E.A., Improved device for measuring scratching activity in patients with pruritus, Med. Biol. Eng. Comput., 36, pp. 220-224, (1998)
[38]  
Bergasa N.V., Talbot T.L., Alling D.W., Et al., A controlled trial of naloxone infusions for the pruritus of chronic cholestasis, Gastroenterology, 102, pp. 544-549, (1992)
[39]  
Bergasa N.V., Talbot T.L., Schmitt J.P., Et al., Open label trial of oral nalmefene therapy for the pruritus of cholestasis, Hepatology, 27, pp. 679-684, (1998)
[40]  
Bergasa N.V., Alling D.W., Talbot T.L., Et al., Naloxone ameliorates the pruritus of cholestasis: Results of a double-blind randomized placebo-controlled trial, Ann. Intern. Med., 123, pp. 161-167, (1995)